Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 4, 2007, Pages 425-426

  Saleh, Husain A ^a   Abu Rashed, Ahmad H ^a  

^a SINAI GRACE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EDITORIAL; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; REPRODUCIBILITY OF RESULTS;

EID: 37549057373     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004; 24: 89-97.
2. Sporea I, Sirli R, Popescu A, Cornianu M, Manciu C, Focsa M. The quality of the fragment obtained by liver biopsy for staging chronic hepatitis. J Gastrointestin Liver Dis 2007; 16: 263-266.
3. Gebo KA, Herlong HF, Torbenson MS, et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36(5 Suppl 1): S161-172.
4. Van Leeuwen DJ, Wilson L, Crowe DR. Liver biopsy in the mid-1990s: questions and answers. Semin Liver Dis 1995;15: 340-359.
5. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 1999; 45 Suppl 4: IV1-IV11.
6. Farrell RJ, Smiddy PF, Pilkington RM, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol 1999; 30: 580-587.
7. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-173.
8. Petz D, Klauck S, Rohl FW, Malfertheiner P, Roessner A, Röcken C. Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy. Virchows Arch 2003; 442: 238-244.
9. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-244.
10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.
11. Abdi W, Milln JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667-669.
12. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525.
13. Bedossa P, Dargčre D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.
14. Brunetti E, Silini E, Pistorio A, et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. J Hepatol 2004; 40: 501-506.